Position in LLY
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$361,425,470
+$350,743,297 QoQ
Shares Held
301,331
+707.8% QoQ
Ownership
0.032%
of shares outstanding
% of Portfolio
6.02%
of 13F equity value
Holder Rank
#189
of 4,627 holders
Holding Since
Sep 2020
8 quarters on record
Voting authority
Sole 68%
Shared 0%
None 32%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Alphinity Investment Management Pty Ltd holds $361,425,470 across 1 Drug Manufacturers - General name. LLY ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
301,331 | $361,425,470 |
All Filings in LLY
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $361,425,470 | 301,331 | Shares | Sole | 2026-07-29 | |
| 2022-03-31 | $10,682,173 | 37,302 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $12,296,761 | 44,518 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $7,571,046 | 32,768 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $12,638,748 | 55,066 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $85,699,004 | 458,725 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $55,272,475 | 327,366 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $38,529,309 | 260,298 | Shares | Sole | 2021-02-10 | |
| No filing history on record for this holder in this stock. | ||||||